zileuton has been researched along with Anemia, Sickle Cell in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arumugam, PI; Brandt, EB; Carmeliet, P; Eiymo Mwa Mpollo, MS; Hershey, GK; Jonck, B; Kalra, VK; Le Cras, TD; Lindsey, M; Loberg, A; Malik, P; Pillis, D; Ratner, N; Rizvi, T; Shanmukhappa, SK; Tiwari, S; Wills-Karp, M | 1 |
Baliga, BS; Haynes, J; Obiako, B; Ofori-Acquah, S; Pace, B | 1 |
Baliga, BS; Gardner, R; Haynes, J; Kuvibidila, S; Ode, D; Velez, M; Warrier, R; Yu, L | 1 |
Haynes, J; Hester, RB; King, JA; Obiako, B; Ofori-Acquah, S | 1 |
Mazziotti, DA; Rohrman, BA | 1 |
5 other study(ies) available for zileuton and Anemia, Sickle Cell
Article | Year |
---|---|
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.
Topics: Anemia, Sickle Cell; Animals; Asthma; Disease Models, Animal; Hydroxyurea; Interleukin-13; Leukotrienes; Mice; Mice, Knockout; Placenta Growth Factor; Pregnancy Proteins; Th2 Cells | 2016 |
Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.
Topics: Anemia, Sickle Cell; Arginine; Case-Control Studies; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Humans; Hydroxyurea; K562 Cells; Nitric Oxide; Nitric Oxide Synthase; Signal Transduction | 2004 |
Differential effects of hydroxyurea and zileuton on interleukin-13 secretion by activated murine spleen cells: implication on the expression of vascular cell adhesion molecule-1 and vasoocclusion in sickle cell anemia.
Topics: Anemia, Sickle Cell; Animals; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Female; Hydroxyurea; Interleukin-13; Lymphocytes; Mice; Mice, Inbred C57BL; Spleen; Vascular Cell Adhesion Molecule-1; Vasoconstriction | 2005 |
Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells.
Topics: Anemia, Sickle Cell; Animals; Annexin A5; Arachidonate 5-Lipoxygenase; Cell Adhesion; Endothelium, Vascular; Enzyme Inhibitors; Erythrocytes, Abnormal; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Male; Neutrophil Activation; Neutrophils; Phosphatidylserines; Rats; Rats, Sprague-Dawley | 2006 |
Quantum chemical design of hydroxyurea derivatives for the treatment of sickle-cell anemia.
Topics: Anemia, Sickle Cell; Antisickling Agents; Free Radicals; Humans; Hydroxyurea; Nitric Oxide Donors; Quantum Theory | 2005 |